Publication: Frequency, Distribution, and Impact on Prognosis of BCR-ABL1 Kinase Domain Mutations in Tyrosine Kinase Inhibitor Resistant Chronic Myelogenous Leukemia Patients
| dc.authorscopusid | 57200789282 | |
| dc.authorscopusid | 56689513900 | |
| dc.authorscopusid | 6603090143 | |
| dc.authorscopusid | 57016887400 | |
| dc.authorscopusid | 6504527476 | |
| dc.authorscopusid | 55918180300 | |
| dc.authorscopusid | 55918180300 | |
| dc.contributor.author | Akar, Ö.S. | |
| dc.contributor.author | Turgut, M. | |
| dc.contributor.author | Özatli, D. | |
| dc.contributor.author | Abur, Ü. | |
| dc.contributor.author | Kelkitli, E. | |
| dc.contributor.author | Altundaǧ, E. | |
| dc.contributor.author | Ogǔr, G. | |
| dc.date.accessioned | 2025-12-11T00:34:39Z | |
| dc.date.issued | 2025 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Akar] Omer Salih, Department of Medical Genetics, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Turgut] Mehmet, Department of Internal Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Özatli] Düzgün, Department of Internal Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Abur] Ummet, Department of Medical Genetics, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Kelkitli] Engin, Department of Internal Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Altundaǧ] Engin, Department of Medical Genetics, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Ogǔr] Gönül, Department of Medical Genetics, Ondokuz Mayis University, Medical School, Samsun, Turkey | en_US |
| dc.description.abstract | Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the BCR | en_US |
| dc.identifier.doi | 10.52142/omujecm.42.1.10 | |
| dc.identifier.endpage | 52 | en_US |
| dc.identifier.issn | 1309-4483 | |
| dc.identifier.issn | 1309-5129 | |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.scopus | 2-s2.0-105002257568 | |
| dc.identifier.scopusquality | Q4 | |
| dc.identifier.startpage | 48 | en_US |
| dc.identifier.uri | https://doi.org/10.52142/omujecm.42.1.10 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/37648 | |
| dc.identifier.volume | 42 | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Ondokuz Mayis Üniversitesi | en_US |
| dc.relation.ispartof | Journal of Experimental and Clinical Medicine (Turkey) | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | ABL1 TKD Mutations | en_US |
| dc.subject | Chronic Myeloid Leukemia | en_US |
| dc.subject | IM Resistance | en_US |
| dc.title | Frequency, Distribution, and Impact on Prognosis of BCR-ABL1 Kinase Domain Mutations in Tyrosine Kinase Inhibitor Resistant Chronic Myelogenous Leukemia Patients | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
